News Release

Breast cancers: ruptures in cell nuclei promotes tumor invasion

Cell nuclei protect the DNA. Nuclei can rupture when cells are deformed, causing DNA damage. In the case of breast cancer, this damage makes tumour cells more invasive, with increased risk of metastasis.

Peer-Reviewed Publication

CNRS

Image of human tumour cells invading a collagen matrix

image: Image of human tumour cells invading a collagen matrix. The nuclei are stained in blue and the portion of the extracellular matrix degraded by the cells is red. view more 

Credit: Guilherme Nader/Institut Curie

The nucleus of a cell fills a crucial function: to protect cell DNA and enable its proper use. But it can be deformed, or even temporarily fractured, if the cell itself is compressed and deformed, for example, in the case of migration or proliferation. This compression then leads to DNA damage. The consequences are accelerated ageing for healthy cells and the acquisition of invasive properties for breast tumour cells, as has just been shown by a research team from CNRS, Institut Curie and INSERM1.

These scientists have shown that when cells are compressed and that breaks the nucleus, DNA can come into contact with a DNA-destroying enzyme called TREX1. TREX1’s normal function is to protect the cell by destroying the DNA of viruses that try to infect it, but under these unusual conditions it attacks the cell DNA.

In healthy tissue, the cells then show signs of ageing and stop dividing. However, the research team has observed that the consequences are different in a breast tumour: instead of killing the cancer cells, the damage caused by TREX1 will make them more invasive. For example, when the tumour grows too much, the cells are compressed and then acquire the ability to destroy their environment to invade neighbouring tissues, with increased risk of metastasis.

These results reveal the importance of the enzyme TREX1 in the development of breast cancer and also in ageing. The scientists now want to identify and test molecules that could block its activity. Because TREX1 has an important role in modulating inflammation and immunity, these inhibitors may have many applications in therapy.

 

Notes

1- In France, researchers from the Laboratoire Biologie Cellulaire et Cancer (CNRS/Institut Curie/Sorbonne Université), the Laboratoire Immunité et Cancer (INSERM/Institut Curie), the Laboratoire Physico-chimie Curie (CNRS/Sorbonne Université/Institut Curie), the Laboratoire Processus d'Activation Sélectif par Transfert d'Energie Uni-électronique ou Radiatif (CNRS/ENS – PSL/Sorbonne Université) and the Centre de Recherche des Cordeliers (INSERM/Université de Paris/Sorbonne Université) participated in this work.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.